Articles
Transverse Myelitis and Multiple Sclerosis: A Neurologist's Guide to Diagnosis, Recovery, and Outlook
Published: April 4, 2026
Author: Dr. Achillefs Ntranos MD
Transverse myelitis often comes as a surprise — new neurological symptoms that develop over days and raise questions you weren't expecting to face. Once you start reading about it, you'll quickly run into the one that brings most people to a neurologist's office: does this mean I have multiple sclerosis?
The short answer is: sometimes, but often not. Transverse myelitis can be a one-time event with no further consequences, or it can be the first sign of MS or another autoimmune condition. The distinction matters enormously for treatment, and it's one that requires careful diagnostic work — not guesswork.
In my practice as an MS specialist in Beverly Hills, I see patients at every stage of this journey — from the initial emergency room visit to years of follow-up care. This guide will walk you through what transverse myelitis is, how it connects to multiple sclerosis, what the diagnostic workup involves, and what recovery actually looks like.
What Is Transverse Myelitis?
Transverse myelitis is an inflammatory condition that attacks the spinal cord. The word "transverse" refers to the inflammation extending across the width of the spinal cord, and "myelitis" simply means inflammation of the spinal cord. When this inflammation damages the myelin — the protective insulation around nerve fibers — it disrupts the signals traveling between your brain and body.
The spinal cord is essentially a highway of nerve fibers connecting your brain to everything below your neck. When a section of that highway becomes inflamed, signals can't get through properly. Depending on where in the spinal cord the inflammation occurs, you might experience problems with your legs, your torso, your arms, your bladder, or all of the above.
Transverse myelitis can occur as an isolated event (called idiopathic transverse myelitis), or it can be the first clinical attack of a broader condition like multiple sclerosis, neuromyelitis optica (NMO), or MOGAD. This distinction is critically important because it determines your long-term treatment plan and prognosis.
Why the cause matters
Identifying the underlying cause of transverse myelitis is not just an academic exercise. MS, NMO, and MOGAD each require different long-term treatments. A therapy that works well for MS may be ineffective — or even harmful — for NMO. This is why a thorough diagnostic workup with a neurologist experienced in demyelinating diseases is essential.
Symptoms of Transverse Myelitis
Symptoms of transverse myelitis typically develop over hours to a few days, though in some cases they can evolve over one to two weeks. The hallmark is the rapid onset of neurological problems below a specific level of the spinal cord. Here are the most common symptoms:
| Symptom | What It Feels Like |
|---|---|
| Weakness | Heaviness or difficulty moving the legs, sometimes progressing to partial or complete paralysis |
| Numbness or tingling | Loss of sensation or pins-and-needles below a certain level, often starting in the feet and moving upward |
| Band-like tightness | A squeezing sensation around the chest or abdomen, sometimes called the "MS hug" |
| Pain | Burning, shooting, or stabbing pain in the back, legs, or torso |
| Bladder dysfunction | Urgency, inability to urinate, or incontinence |
| Bowel dysfunction | Constipation or loss of bowel control |
The severity varies widely. Some patients experience mild numbness and slight difficulty walking, while others develop complete paralysis below the waist within hours. The level of the spinal cord affected determines which parts of the body are involved — a lesion in the thoracic spine (mid-back) typically affects the legs and trunk, while a cervical spine (neck) lesion can affect all four limbs.
I often tell patients that the speed and pattern of symptom onset gives us important clues. A very rapid onset over hours with severe symptoms may suggest NMO, while a more gradual progression over days with partial symptoms is more typical of MS-related transverse myelitis.
How Transverse Myelitis Is Connected to MS
This is the question that brings most patients to my office: Is my transverse myelitis actually MS?
The short answer is that transverse myelitis can be the first clinical attack of MS — what neurologists call a clinically isolated syndrome (CIS). CIS is a single episode of neuroinflammation that looks like MS but hasn't yet met the full diagnostic criteria. When that episode involves the spinal cord, it presents as transverse myelitis.
Risk Factors for MS After Transverse Myelitis
Not everyone with transverse myelitis goes on to develop MS. Research has identified several key factors that increase the likelihood:
- Brain MRI lesions: If your brain MRI shows white matter lesions characteristic of demyelination at the time of your transverse myelitis, the risk of developing MS is significantly higher — roughly 60-80% within 10-15 years. If the brain MRI is completely normal, the risk drops to approximately 10-20%.
- Oligoclonal bands: The presence of oligoclonal bands in your spinal fluid (detected through a lumbar puncture) is a strong indicator of an ongoing immune process in the central nervous system, which raises the probability of MS.
- Short-segment lesion: MS-related spinal cord lesions tend to be short (spanning fewer than two vertebral segments) and located at the periphery of the cord. Longer lesions spanning three or more segments are more characteristic of NMO or MOGAD.
- Partial symptoms: MS-related transverse myelitis tends to produce partial or asymmetric symptoms rather than complete paralysis.
Understanding where you fall on this spectrum is essential, and it's exactly what the 2024 McDonald criteria are designed to determine. These updated diagnostic criteria allow neurologists to identify MS earlier than ever before — sometimes from a single attack if specific MRI and laboratory findings are present.
Early diagnosis changes outcomes
In my experience, the patients who do best are those who get a definitive diagnosis early. If transverse myelitis is the first attack of MS, starting disease-modifying therapy promptly can dramatically reduce the risk of future relapses and long-term disability. This is why I recommend that every patient with transverse myelitis have a comprehensive evaluation by a neurologist experienced in demyelinating diseases.
Diagnosis: How Neurologists Evaluate Transverse Myelitis
When a patient presents with suspected transverse myelitis, the diagnostic workup has two goals: confirm the spinal cord inflammation and determine its cause. Here is what a thorough evaluation typically involves:
Spinal Cord MRI
This is the most important initial test. A spinal cord MRI with contrast can visualize the inflamed area directly, showing where the lesion is, how long it extends, and whether it enhances with contrast dye (indicating active inflammation). The characteristics of the lesion — its length, location within the cord, and pattern — provide critical clues about the underlying diagnosis.
Brain MRI
A brain MRI is essential even though the symptoms are in the spinal cord. If the brain shows white matter lesions typical of demyelination, this significantly raises the probability that the transverse myelitis is the first attack of MS. Understanding your MRI findings is an important part of making sense of your diagnosis.
Lumbar Puncture
A lumbar puncture (spinal tap) provides spinal fluid for analysis. Key findings include:
- Oligoclonal bands — present in over 90% of MS patients and a strong predictor of MS after a first attack
- Elevated white blood cells — indicates active inflammation in the central nervous system
- Cell count and protein levels — help distinguish between different causes of myelitis
Blood Tests
Blood tests are essential for ruling out conditions that can mimic transverse myelitis:
- Aquaporin-4 (AQP4) antibodies — positive in NMO
- MOG antibodies — positive in MOGAD
- ANA, ESR, and other autoimmune markers — to evaluate for systemic autoimmune diseases like lupus or sarcoidosis
- Vitamin B12 and copper levels — nutritional deficiencies that can cause spinal cord problems
In my practice, I run a comprehensive panel on every patient with a first episode of transverse myelitis. I've seen cases where the initial presentation looked like textbook MS but turned out to be NMO — a distinction that fundamentally changes the treatment approach. Getting the diagnosis right the first time is critical.
Treatment: Acute and Long-Term
Acute Treatment
The first priority is reducing the spinal cord inflammation as quickly as possible. Time matters — the sooner inflammation is controlled, the better the chances for recovery.
High-dose intravenous steroids are the standard first-line treatment. A typical course is 1,000 mg of IV methylprednisolone daily for three to five days. Steroids reduce inflammation and can accelerate recovery, though they do not change the ultimate outcome on their own.
Plasma exchange (plasmapheresis) is used when patients don't respond adequately to steroids. This procedure filters the blood to remove the antibodies causing the attack. It is particularly effective in severe cases and in NMO-related myelitis.
Long-Term Treatment
Long-term treatment depends entirely on the underlying diagnosis:
- If the transverse myelitis is the first attack of MS: Starting disease-modifying therapy is critical. Modern MS treatments like anti-CD20 therapies are highly effective at preventing future relapses and preserving neurological function. The earlier treatment begins, the better the long-term outcomes.
- If it is NMO or MOGAD: Different medications are needed. MS treatments may not work for NMO and can sometimes make it worse.
- If it is idiopathic (no underlying cause found): Close monitoring with serial MRIs is recommended. Some patients never have another episode, while others may develop MS or another condition over time.
I often tell patients that the acute treatment is about putting out the fire, while the long-term treatment is about preventing the next fire from starting. Both are essential.
Recovery and Prognosis
Recovery from transverse myelitis follows what neurologists sometimes call the "rule of thirds":
- One-third of patients recover well, with little to no lasting symptoms
- One-third have moderate residual deficits — some weakness, numbness, or bladder issues that persist but are manageable
- One-third experience significant permanent disability, including difficulty walking or ongoing need for bladder management
Recovery typically begins within one to three months after the acute episode and can continue for up to two years. The most rapid improvement usually occurs in the first three to six months. Several factors influence the prognosis:
- Speed of treatment: Patients who receive high-dose steroids early tend to have better outcomes
- Severity of initial symptoms: Patients with complete paralysis at onset generally have a harder recovery than those with partial symptoms
- Underlying cause: MS-related transverse myelitis tends to have a somewhat better recovery profile than NMO-related episodes
- Rehabilitation: Physical therapy, occupational therapy, and in some cases bladder rehabilitation play a significant role in maximizing recovery
Recovery is a process, not an event
I tell my patients to think of recovery as a marathon, not a sprint. Some improvement may be obvious within weeks, but meaningful changes can continue for many months. The brain and spinal cord have a remarkable ability to adapt and compensate, especially with consistent rehabilitation and effective disease management.
When to Seek a Specialist
Not all neurologists have specialized training in demyelinating diseases. If you or a loved one has been diagnosed with transverse myelitis, I recommend seeking evaluation from a neurologist who specializes in MS and related conditions. This is especially important if:
- Your brain MRI shows lesions that haven't been fully explained
- You've been told you have CIS or "possible MS" and are unsure about next steps
- You want a second opinion on whether to start disease-modifying therapy
- Your symptoms are not improving as expected after treatment
- You've had more than one episode of neurological symptoms
As an MS specialist, I see the full spectrum of demyelinating diseases and can help distinguish between conditions that may look similar on the surface but require very different treatment strategies. Whether you're in the Los Angeles area for an in-person visit or prefer a telehealth consultation, getting the right expertise early can make a meaningful difference.
If you're noticing early signs of MS or have been through an episode of transverse myelitis and want clarity on what comes next, I encourage you to reach out.
Schedule a Consultation
Book an appointment with Dr. Ntranos for expert evaluation of transverse myelitis, spinal cord symptoms, or a possible MS diagnosis.
NMO vs MOGAD vs MS
Learn how neurologists distinguish between demyelinating conditions that can cause transverse myelitis.
Understanding Your MS MRI
If your MRI shows lesions, learn what different patterns mean for your diagnosis and treatment.
Frequently Asked Questions
What is transverse myelitis?
Transverse myelitis is an inflammatory condition that damages the spinal cord's myelin, causing sudden symptoms like weakness, numbness, pain, and bladder problems below the affected level. It can occur on its own or as the first sign of a condition like multiple sclerosis or NMO. The term "transverse" refers to the inflammation extending across the width of the spinal cord.
Can transverse myelitis turn into MS?
Transverse myelitis can be the first attack of MS, but not all cases lead to an MS diagnosis. Risk factors that increase the likelihood include brain MRI lesions, oligoclonal bands in spinal fluid, and a short-segment lesion pattern. Patients with these features have up to a 60-80% chance of developing MS within 10-15 years. Without these risk factors, the chance is much lower.
What are the symptoms of transverse myelitis?
Symptoms typically develop over hours to days and include weakness or paralysis in the legs (sometimes arms), numbness or tingling below a certain level, band-like tightness around the torso, burning or shooting pain, and bladder or bowel dysfunction. Symptoms can range from mild to severe and usually affect both sides of the body, though one side may be worse.
How is transverse myelitis diagnosed?
Diagnosis involves a spinal cord MRI to visualize inflammation, brain MRI to check for additional lesions that might suggest MS, blood tests to rule out other causes like NMO and MOGAD, and often a lumbar puncture to analyze spinal fluid for inflammatory markers and oligoclonal bands. The pattern and extent of the spinal cord lesion provides important clues about the underlying cause.
What is the recovery outlook for transverse myelitis?
Recovery varies widely. About one-third of patients recover well with minimal lasting symptoms, one-third have moderate residual deficits, and one-third experience significant permanent disability. Recovery typically begins within one to three months and can continue for up to two years. Early treatment with high-dose steroids and identifying the underlying cause are the most important factors for a good outcome.
How is transverse myelitis treated?
Acute treatment involves high-dose intravenous or oral steroids to reduce inflammation quickly. If steroids are insufficient, plasma exchange (plasmapheresis) may be used. Long-term treatment depends on the underlying cause — if transverse myelitis is the first attack of MS, starting disease-modifying therapy is critical to prevent future attacks. Rehabilitation including physical therapy and occupational therapy supports recovery.
About the Author
Dr. Achillefs Ntranos MD
Board-Certified Neurologist
Achilles Neurology Clinic
Dr. Achillefs Ntranos MD is a board-certified neurologist and MS specialist known for his thorough evaluations and compassionate approach. Originally from Greece, he trained at Johns Hopkins University and Mount Sinai Hospital before founding Achilles Neurology Clinic in Beverly Hills to deliver comprehensive, patient-centered neurological care. He specializes in MS, autoimmune neurology, neuropathy, headaches, and other neurological disorders, blending research-driven insights with personalized treatment plans.